The tweet was deleted by the author.
But we saved everything 🙂.
Olema Pharmaceuticals has published its financial and operating results for the fourth quarter and full-year 2025.
The company also shared updates on its recent progress and outlined anticipated milestones for the coming period. Further details regarding the reported figures and company outlook can be accessed through its official announcement.
Olema's trajectory remains under close observation following these financial disclosures, building on its recent strategic visibility. The company's leadership approach, highlighted during the CEO’s participation at the TDCowen Health Care Conference fireside chat in Boston, continues to shape investor expectations as Olema navigates forthcoming milestones.